Iran participates in the first D-8 Health Experts Meeting in Cairo, and regional health cooperation guides much of its agenda. The Iranian delegation arrives with a plan to exchange practical experience and to expand coordinated health initiatives. Deputy Health Minister Sajjad Razavi leads the group and outlines national strategies for improved public health systems.
During the opening sessions, member states explore new approaches for stronger disease control. They examine rising non-communicable diseases and propose shared programs for early prevention. Furthermore, they review maternal and newborn health issues and search for effective intervention models. Each delegation introduces national successes and seeks ideas for broader collaboration.
Iran highlights its recent progress in diabetes management. The team also explains comprehensive cardiovascular care efforts across the country. Additionally, Iranian officials share screening methods that boost early detection. They emphasize prevention because it reduces long-term medical costs. Their presentations illustrate how regional health cooperation supports better policy design.
Delegates also discuss major communicable diseases. Many participants analyze surveillance gaps and propose joint monitoring systems. Moreover, they consider options to improve laboratory capacity across the region. These discussions help member states identify urgent priorities and align future health programs.
Throughout the meeting, representatives evaluate the idea of a D-8 Working Group on Health. Such a group could coordinate long-term strategies and unify regional planning. It may also support technical training and create opportunities for shared research. Delegates note that coordinated structures often accelerate effective policymaking.
Iran stresses its wider achievements in national healthcare development. Officials describe expanded primary health care services in rural areas. They also note improved vaccination coverage and significant declines in maternal mortality. These accomplishments reflect consistent investment in community-based care.
Later discussions focus on pharmaceutical regulation. Iran aims to reach a higher regulatory maturity level to support medical exports. Stronger regulation also enhances global health security and increases trust in regional manufacturing. WHO leaders acknowledge Iran’s commitment and encourage continued progress.
WHO EMRO officials express interest in deeper cooperation with Iran. They praise the country’s support for refugee health services and recognize its technical capacities. Consequently, both sides plan new pathways for partnership. Iran signals readiness for expanded projects because regional health cooperation strengthens collective resilience.